Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Some patients may switch to copycats of another GLP-1 drug, semaglutide, the main ingredient in the type 2 diabetes drug Ozempic and the weight loss drug Wegovy. Semaglutide remains on the FDA’s ...

The FDA approved Zepbound (tirzepatide ... improves obstructive sleep apnea (OSA), it’s likely related to weight loss, because obesity is a factor that increases the risk of OSA, says Nathan ...

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...

Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...

New an­ti-obe­si­ty drugs should meet a min­i­mum lev­el of weight loss to be con­sid­ered for ap­proval, the FDA said Tues­day, tak­ing the rare step of … ...

1. Obesity drugs are only going to become more common. With the so-called Ozempic boom, consumers are more aware of these drugs then ever and are consequently asking their doctors about them.

But hCG is not approved for weight loss and there’s no evidence it helps. The U.S. FDA warns against its use, saying that very restrictive diets, such as the hCG diet, are dangerous. The history ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly producing misleading marketing content for drugs resembling Ozempic and Wegovy.